Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Amgen, Inc.
(NQ:
AMGN
)
104.53
USD
+0.29 (+0.28%)
Official Closing Price
/ Updated:
5:20 PM EDT, May 22, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Amgen, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
35
36
Next >
Perfect Trade Setups, How to Play NOV, AMGN, NSC and USB
April 08, 2013
from
Marketwired News Releases
The Straight Truth, Investing in WMT, FCX, AMGN and MON
April 05, 2013
from
Marketwired News Releases
Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles for Recoupment Policies Covering Major Compliance Failures
April 04, 2013
from
PR Newswire
Special Offer for Shareholders of KO, AET, AMGN and AIG
April 04, 2013
from
Marketwired News Releases
Strategy Behind Our Success, We Get in Early: AMGN, MU, LOW and SLB
April 02, 2013
from
Marketwired News Releases
Morning Research on Amgen, Affymax, Vertex Pharma, Questcor Pharma, and Repros Therapeutics
April 01, 2013
from
PR Newswire
The Reason It Trades, What's Moving BSX, AMGN, ASML and BBY
April 01, 2013
from
Marketwired News Releases
The Reason It Trades, What's Moving VMED, AMGN, BMY and DD
March 27, 2013
from
Marketwired News Releases
Key to Success, How to Profit: LULU, VZ, EMC and AMGN
March 25, 2013
from
Marketwired News Releases
The Real Story Behind BIDU, YHOO, AIG and AMGN
March 22, 2013
from
Marketwired News Releases
Critical Alerts For Las Vegas Sands, Amgen, Edwards Lifesciences, Valeant Pharmaceuticals, and China Mobile Released By InvestorsObserver
March 21, 2013
from
PR Newswire
PsiOxus Therapeutics Comments on Phase III Results from Amgen’s Oncolytic Vaccine
March 20, 2013
from
Business Wire News Releases
RBCC Forms Joint Venture With Cutting-Edge Drug Delivery Company TheraKine
March 20, 2013
from
Business Wire News Releases
Amgen Announces Top-Line Results Of Phase 3 Talimogene Laherparepvec Trial In Melanoma
March 19, 2013
from
PR Newswire
Did You Miss DTV, AMGN, PM and F
March 18, 2013
from
Marketwired News Releases
Innovative Product Portfolios Ride Commercialization & Global Expansion - Research Report on Amgen, Onyx Pharmaceuticals, Alexion Pharmaceuticals, BioMarin Pharmaceutical and Incyte
March 18, 2013
from
PR Newswire
Special Situation Coming Soon, a Look Inside CELG, CVX, AMGN and EBAY
March 15, 2013
from
Marketwired News Releases
A Forward Look, the Year Ahead - Research Report on Amgen, Inc., Bristol Myers Squibb Co., Ann Inc., Limited Brands, Inc. and AMETEK, Inc.
March 14, 2013
from
PR Newswire
RBCC: Tech Innovations Drive Big Growth in $60 Billion Drug Delivery Market
March 13, 2013
from
Business Wire News Releases
Special Offer for Shareholders of GOOG, AMGN, PBR and GILD
March 12, 2013
from
Marketwired News Releases
BioMarin Pharma, Amgen, Sarepta Therapeutics, Chelsea Therapeutics Intl., and Theravance Early Briefing and Review
March 07, 2013
from
PR Newswire
Amgen Announces 2013 Second Quarter Dividend
March 06, 2013
from
PR Newswire
The Reason It Trades, What's Moving AMGN, MMM, BA and VIAB
March 06, 2013
from
Marketwired News Releases
RBCC Nears Finalization of Partnership Agreement with Leading-Edge Pharmacogenomics Labs
March 06, 2013
from
Business Wire News Releases
Key to Success, How to Profit: AMZN, AMGN and BIDU
March 05, 2013
from
Marketwired News Releases
Next Week's Trade Setups, What's in Store for WRC, AMGN, HLF and MNST
March 01, 2013
from
Marketwired News Releases
Amgen To Present At The Cowen and Company 33rd Annual Health Care Conference
March 01, 2013
from
PR Newswire
The Real Story Behind MON, FTE, RRC and AMGN
February 28, 2013
from
Marketwired News Releases
Science Behind the Numbers, The Business of Health - Research Report on Endo Health Solutions Inc, Actavis Inc, Mylan Inc., Elan Corporation, plc and Amgen, Inc.
February 28, 2013
from
PR Newswire
RBCC Opens Talks to Help Develop Revolutionary Breakthrough in $60 Billion Drug Delivery Market
February 27, 2013
from
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
35
36
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here